Lupin Q2 Results Live : Lupin declared their Q2 results on November 7, 2024, reporting a robust performance with a topline ...

Drugmaker Lupin aims to be part of the first wave of generic drugmakers to make GLP-1 receptor agonists products, used to ...

Macquarie analysts described the results as an "all-round beat". Although revenue aligned closely with their forecast, Ebitda ...

Pharma major Lupin Ltd reported a robust 74.1% year-on-year rise in its consolidated net profit, reaching Rs 852.63 crore for ...

Ramesh Swaminathan, Global CFO of Lupin discusses the impact of Trump's win on the Indian pharmaceutical sector. Growing ...

The company posted a net profit of Rs 852.6 crore in the quarter ended September in comparison to Rs 489.7 crore in the ...

Lupin’s average revenue will potentially increase 9.2 per cent Y-o-Y to Rs 5,502 crore as against Rs 5,038 crore in Q2FY24.

North America Q2 sales were Rs 1,971.1 crore, up 5.6 percent compared to Rs 1,866.6 crore, accounting for 36 percent of Lupin ...

Global pharma major Lupin Limited on Friday announced that it has received tentative approval from the United States Food and ...

Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for ...

Shares of Lupin Ltd. fell 2.82 per cent to Rs 2126.9 in Tuesday's trade as of 11:15AM (IST) even as the benchmark Nifty ruled ...

Lupin Limited delivered a strong financial performance for the second quarter, surpassing market expectations. Net profit for ...